Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis”

992 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 992 results

Large-scale testing (Phase 3)Study completedNCT00723528
What this trial is testing

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 158
Early research (Phase 1)UnknownNCT05258331
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
GC Cell Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00428974
What this trial is testing

Safety and Efficacy Study of CF101 to Treat Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 76
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01622348
What this trial is testing

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Actively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis
Idera Pharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT06176768
What this trial is testing

LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 33
Large-scale testing (Phase 3)Study completedNCT03518047
What this trial is testing

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Who this might be right for
Psoriasis
AbbVie 50
Large-scale testing (Phase 3)WithdrawnNCT02795416
What this trial is testing

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Not applicableActive Not RecruitingNCT05913817
What this trial is testing

The Evaluation of Injection Site Pain and Adherence in Patients Switching from a Low to High Concentration Adalimumab (AVT-02) Across Multiple Indications.

Who this might be right for
Crohn DiseaseUlcerative ColitisRheumatoid Arthritis+4 more
Jamp Pharma Corporation 600
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Post-approval studies (Phase 4)Study completedNCT03718299
What this trial is testing

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries Limited 55
Early research (Phase 1)Looking for participantsNCT07024602
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Ascletis Pharma (China) Co., Limited 94
Large-scale testing (Phase 3)Study completedNCT01646177
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,346
Large-scale testing (Phase 3)Study completedNCT05637515
What this trial is testing

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
Biocon Biologics Inc. 374
Large-scale testing (Phase 3)Study completedNCT03123471
What this trial is testing

The Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Psoriasis
Amgen 303
Not applicableNot Yet RecruitingNCT06338358
What this trial is testing

Understanding Participation Habits Among Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Power Life Sciences Inc. 500
Post-approval studies (Phase 4)Study completedNCT02148640
What this trial is testing

The NOR-SWITCH Study

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+3 more
Diakonhjemmet Hospital 482
Not applicableStudy completedNCT00227240
What this trial is testing

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 753
Large-scale testing (Phase 3)Study completedNCT00254982
What this trial is testing

Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 593
Not applicableLooking for participantsNCT04846959
What this trial is testing

Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

Who this might be right for
Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment
AbbVie 818
Load More Results